Industry News
MRI-guided brain cancer breakthrough - exclusive interview
Aug 08, 2013
Neurosurgeons from the University of California, San Diego (UCSD) have conducted the first real-time MRI-guided gene therapy for patients with brain cancer, advancing the clinical trial of new cancer drug, Toca 511... Read More
BJGP study confirms that GPs are effective at performing skin cancer biopsies, UK
Aug 08, 2013
GPs can effectively perform biopsies to test for melanoma without leading to poorer long term outcomes for patients, according to research in the British Journal of General Practice this month... Read More
Novel treatment boosted selective immune attack on leukemia cells in post-transplant patients
Aug 08, 2013
Patients with advanced chronic lymphocytic leukemia (CLL) often receive donor transplants that effectively "reboot" their own immune defenses, which then attack and potentially cure the hard-to-treat disease. However, there is a high rate of relapse in these patients, and the transplanted immune cells may also harm normal tissues, causing graft-versus-host disease (GVHD)... Read More
A possible future for cancer research without animal testing
Aug 08, 2013
JoVE, the Journal of Visualized Experiments, has published two new methods for scientists to study and treat tumor growth. The methods introduce a lab-born, human tissue structure with replicated human biochemistry - offering scientists the opportunity to grow, observe, and ultimately learn how to treat biopsied human tumor cells... Read More
Scientists put cancer-fighting power back into frozen broccoli
Aug 08, 2013
There was bad news, then good news from University of Illinois broccoli researchers this month. In the first study, they learned that frozen broccoli lacks the ability to form sulforaphane, the cancer-fighting phytochemical in fresh broccoli. But a second study demonstrated how the food industry can act to restore the frozen vegetable's health benefits... Read More
Par-1 a new component of the Hippo signaling pathway
Aug 08, 2013
In the development of animals, which is closely controlled by diverse pathways, the regulation of organ size has been a long-standing puzzle... Read More
New findings could lead to drugs that fight back when tumors don't respond to treatment
Aug 08, 2013
Cancer drugs known as ErbB inhibitors have shown great success in treating many patients with lung, breast, colon and other types of cancer. However, ErbB drug resistance means that many other patients do not respond, and even among those who do, tumors commonly come back... Read More
Brain cancer: groundbreaking MRI-guided gene therapy
Aug 08, 2013
Neurosurgeons from the University of California, San Diego (UCSD) have conducted the first real-time MRI-guided gene therapy for patients with brain cancer, advancing the clinical trial of new cancer drug, Toca 511... Read More
"Fork reversal" repair enables tumors to elude anti-cancer drugs
Aug 08, 2013
In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors... Read More
Tumor resistance to anti-angiogenic therapy promoted by immune system molecule
Aug 08, 2013
A team of scientists, led by Napoleone Ferrara, MD, has shown for the first time that a signaling protein involved in inflammation also promotes tumor resistance to anti-angiogenic therapy... Read More
Previous Page Next Page